Central Laboratories White Papers & Articles

  1. Bringing Intelligence Into The Flow Of Clinical Trials 4/16/2026

    AI-driven trial intelligence turns complex data into real-time insight, enabling earlier risk detection, stronger oversight, and smarter decisions across the trial lifecycle.

  2. Managing Opportunities And Risks In Generative AI Use For Clinical Research 4/15/2026

    Explore how to bridge the gap between generative AI potential and clinical regulations through smarter oversight, adversarial agents, and a workforce prepared for human-AI collaboration.

  3. Understanding When AI Models Need To Be Validated For Regulated Industries 4/15/2026

    Focus AI validation on decision impact rather than just algorithms. Aligning assurance with intended use and human oversight ensures safety while enabling faster, more compliant adoption.

  4. Improving Rare Disease Recruitment With Data And AI 4/15/2026

    Finding patients for rare disease clinical trials can be an uphill battle; fortunately, there are ways sponsors can address the most common stumbling blocks in the recruitment process.

  5. Futureproofing Post-Approval Compliance 4/15/2026

    In the post-approval stage, a synergistic operating model brings PV and regulatory functions under one umbrella: a single governance structure with shared decision cycles, templates, and evidence.

  6. How Sponsors Can Ensure Their Sites Are Aligned With ICH E6 R3 4/14/2026

    Updated GCP expectations reshape sponsor–site collaboration. Clear guidance on systems, data governance, and monitoring reduces risk, strengthens oversight, and supports compliance with ICH E6(R3).

  7. Using AI To Close Critical Clinical Trial Gaps 4/13/2026

    Clinical trials face rising data and protocol complexity, driving delays and failures. Using intelligence-driven planning helps predict feasibility, flag enrollment risks early, and build more resilient studies.

  8. The AI-Powered Workflow Advantage 4/13/2026

    Clinical trial complexity is outpacing traditional teams. Discover how unifying start-up and execution through intelligent workflows can reduce delays, automate budgets, and accelerate delivery.

  9. Empowering People Through Data: Redefining Digital Transformation In Pharma 4/7/2026

    Discover how human-centered digital transformation, powered by data, AI, and inclusive leadership, can turn insights into action and drive more responsible, meaningful innovation in pharma.

  10. Paper COAs In 2026? It's Not "Cheaper," It's Riskier 4/1/2026

    Paper-based assessments add operational and regulatory risk — from poor data quality to delayed insights — quietly threatening timelines, compliance, and trial confidence.